![](/img/cover-not-exists.png)
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer
Laura J. Havrilesky, Robin Pokrzywinski, Dennis Revicki, Robert V. Higgins, Lawrence R. Nycum, Matthew F. Kohler, Andrew Berchuck, Evan R. Myers, Angeles Alvarez SecordVolume:
118
Year:
2012
Language:
english
Pages:
6
DOI:
10.1002/cncr.26199
File:
PDF, 206 KB
english, 2012